USA - NASDAQ:OKYO - GG00BMFG5F62 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to OKYO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-02 | HC Wainwright & Co. | Initiate | Buy |
8 analysts have analysed OKYO and the average price target is 10.2 USD. This implies a price increase of 275% is expected in the next year compared to the current price of 2.72.
The consensus rating for OKYO PHARMA LTD (OKYO) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering OKYO PHARMA LTD (OKYO) is 8.